Scientific program

30th Cardiovascular Surgical Symposium – CSS 15.30 – 18.30 Interactive Cardiovascular Training for Residents 15.30 – 16.00 Aortic valve disease: the view of the cardiologists 16.00 – 16.30 Aortic valve disease: the view of the surgeon S. Folkmann, T. Fleck, M. Grabenwöger (Vienna) Wetlab: Aortic valve replacement and coronary artery bypass grafting 18.30 Welcome Reception at the congress venue for al participants of the meeting 9.00 – 12.00 Interactive Cardiovascular Training for Residents 9.00 – 9.30 Practical aspects of PM-insertion 9.30 – 10.00 How to train cardiac surgeons S. Folkmann, M. Gorlitzer, G. Laufer (Vienna) Aortic valve replacement and coronary artery bypass grafting 30th Cardiovascular Surgical Symposium – CSS SUNDAY, March 4, 2012 – SCIENTIFIC PROGRAM G.Laufer, M. Grabenwöger, M. Deutsch (Vienna) 15.30 – 17.00 Session A: Cardiac Arrhythmias: Incidence and Diagnosis Chair: M. Brunner (Vienna), V. Falk (Zurich) • State-of-the-art: PM-therapy for SSS und AV-block • Ventricular arrhythmias and defibril atortherapy PRO-CON SESSION:
• Pacemakers should be implanted by surgeons • Pacemaker should be implanted by cardiologist 17.30 – 19.00 Session B: Coronary Artery Disease Chair: M .Grabenwöger (Vienna), G. Laufer (Vienna) UPDATE ON THE SYNTAX TRIAL:
• Guidelines for the treatment of coronary artery disease: 30th Cardiovascular Surgical Symposium – CSS MONDAY, March 5, 2012 – SCIENTIFIC PROGRAM Chair: M. Grimm (Innsbruck), W. Wandschneider (Klagenfurt) • Intraoperative, autologous CD133+ stem cel isolation and TMLR-supported transplantation during CABG • The prevention and management of severe complications during congenital heart disease interventions • Should all moderate coronary lesions be grafted during primary coronary bypass surgery? An analysis of disease progression during angiographic surveil ance in a trial of conduits • Risk stratification model and internal mammary artery grafting in patients undergoing coronary artery bypass surgery within 24 hours of a myocardial infarction • First successful postoperative activation of enCor SQ • Factors influencing the choice for endoscopic vein harvesting in patients undergoing coronary artery bypass grafting: a single center experience • Human vascular organ culture under flow conditions • CPB-assisted PCI in high risk patients with multivessel coronary disease • Emergency coronary artery bypass surgery - • Revascularization of occluded or stenotic subclavian veins is supported by laser lead extraction • Novel new rotary VAD to address the economic limitations on destination therapy S. Westaby (Oxford) • Study on decellularized porcine pulmonary valved conduits • Isolated right coronary artery fistula to left ventricle: • Coronary arteries aneurysms associated with giant bilateral aneurysms of Iliac arteries. Case report • The Medtronic 3830 SelectSecure pacing lead is safe and favorable in pediatric pacemaker patients • Laser enhanced technique for lead extraction • Tear orientated aortic dissection surgery yields both low operative mortality and reoperation rate • Elective transfer from cardiopulmonary bypass to centrifugal pump support in very high risk cardiac surgery • Aortic valve replacement in patients 80 years of age and older 30th Cardiovascular Surgical Symposium – CSS MONDAY, March 5, 2012 – SCIENTIFIC PROGRAM 14.00 – 15.30 Postoperative Care in Cardiac Surgery sponsored by POSTHORAX Chair: S. Folkmann (Vienna), M. Gorlitzer (Vienna) • Wire fixation versus rigid titanium plate after sternotomy – results of a randomized, prospective, multi-center international trial • Elimination of deep and superficial sternal wound infection • POSTHORAX vest: Biomechanical analysis supports clinical findings 15.30 – 17.00 Session A: Pacemaker Therapy 1 Chair: C. Khazen (Vienna), F. Hintringer (Innsbruck) • Biventricular pacing: Current status • Technical aspects of biventricular stimulation • Multipolar left ventricular stimulation 17.30 – 19.00 Session B: Pacemaker Therapy 2 Chair: M. Gaspar (Timisoara), F. Veit (Vienna) • Lead extraction today: potential hazards and benefits • Alternate lead placement for biventricular stimulation KEYNOTE LECTURE:
• 30 years of Cardiovascular Symposium Zürs – 30th Cardiovascular Surgical Symposium – CSS TUESDAY, March 6, 2012 – SCIENTIFIC PROGRAM 8.15 – 11.00 Aortic Valve Symposium sponsored by SYMETIS Chair: T. Fischlein (Nuremberg), R. Seitelberger (Salzburg) • The future of transapical aortic valve implantation • Sutureless valves in the times of TAVI • Rheumatic valve disease – the plight of mil ions • Off-pump transapical mitral valved stent implantation • Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score matched analysis in patients at high surgical risk • Clinical experience with second-generation devices for transcatheter aortic valve implantation – any advantages compared to first generation devices? • Right-sided minitoracotomy vs. full sternotomy approach for • Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute kidney injury in aortic valve replacement patients • Is there any relationship between aortic stiffness and B-type natriuretic peptide in patients with aortic stenosis? • Dramatic ventricle rupture after extended papil ary muscle • Prospective study of 7-day Holter tape follow-up of patients undergoing concomitant atrial fibril ation with high intensity focused ultrasound 30th Cardiovascular Surgical Symposium – CSS TUESDAY, March 6, 2012 – SCIENTIFIC PROGRAM 14.00 – 15.30 Simulation Training in Cardiac Surgery 15.30 – 17.00 Session A: Atrial Fibrillation 1 Chair: K. Huber (Vienna), A. Marmureanu (Los Angeles) • Standard and new anticoagulants for AFib • Catheter ablation and hybrid approach • Subxyphoidal hybrid approach for AFib • Surgical AF ablation: State-of-the-art 17.30 – 19.00 Session B: Atrial Fibrillation 2 N. Ad (Fal s Church), F.X. Roithinger (Mödling) • Surgical exclusion of the LAA: Resection or occlusion • Minimal invasive approaches for LAA occlusion • LAA closure with Amplatzer technology • Watchmann device und PROTECT-AF Trial 30th Cardiovascular Surgical Symposium – CSS WEDNESDAY, March 7, 2012– SCIENTIFIC PROGRAM Chair: M. Deutsch (Vienna), E. Wolner (Vienna) • Risk factors for coronary heart disease in connective tissue diseases • Anterolateral thoracotomy for mitral valve replacement • Midterm results after aortic valve repair by tricuspidalisation and replacement of the right coronary cusp by autologous pericardium • Healthcare disparities in cardiac surgery • Economic aspects of deep sternal wound infections • From appendicitis to aortic valve endocarditis- a delayed destruction of the AV • Thoracoscopic surgical patch insulation of the phrenic nerve as a novel strategy to correct diaphragmatic twitch secondary to cardiac resynchronization therapy • Video-assisted thoracoscopic implantation of left ventricular epicardial leads for ventricular resynchronization • Atrial fibril ation after coronary bypass surgery – • Skeletal Manifestations of the Marfan Syndrome • Mitral valve reconstruction after giant atrial myxoma mechanical damages • An audit of endotracheal cuff pressures on admission to cardiac surgical intensive care • Epoprostenol use in patients with a history of heparin induced Thrombocytopenia: An alternative to thrombin inhibition but significantly cheaper • ROSS operation in patients with bicuspid aortic valve: • Over five years experience with the stentless Sorin Freedom Solo Aortic 30th Cardiovascular Surgical Symposium – CSS WEDNESDAY, March 7, 2012– SCIENTIFIC PROGRAM 14.00 – 15.30 Training in Cardiac Surgery 15.30 – 17.00 Session A: Connective Tissue Disease 1 Chair: H. Reichenspurner (Hamburg), A. Repossini (Brescia) • Rationale for drug therapy and molecular biological strategies for causative treatment of Marfan Syndrome • Mitral valve disease in patients with Marfan Syndrome • Minimal y invasive Mitral repair in Barlow disease • The David operation in Marfan patients • Pediatric manifestations of the Marfan Syndrome 17.30 – 19.00 Session B: Connective Tissue Disease 2 Chair: R. De Paulis (Rome), E. Weigang (Mainz) • The role of stent graft therapy for Marfan Syndrome • Elective Surgery for aortic aneurysms in Marfan patients: When and how • Aortic dissections in Marfan patients • Aortic root disease in patients with Marfan Syndrome 30th Cardiovascular Surgical Symposium – CSS THURSDAY, March 8, 2012 – SCIENTIFIC PROGRAM Chair: T. Fleck (Vienna), G. Weiss (Leipzig) • Update in techniques for lung separation • Studying the effects of treatment methods in patients with atherosclerosis and kinking of carotid artery • Recovery after long-term pulsatile mechanical circulatory support in patient with chronic heart failure: a bridge too far? • Matrix-based repair of acute Type-A aortic dissections as an alternative to conventional glue repair • Superior vena cava atresia caused by Behcet’s disease, a trap with caution • Belorussian experience in mechanical circulatory support • Mechanical circulatory support in children with left ventricular and biventricular assist devices as a bridge to heart transplantation • Focusing on pump thrombosis – contributing factors of chamber change after assist device implantation • Studying the significant role of combined product of Methyluracil and Chloramphenicol in the treatment of lower extremity ischemic ulcers in patients with peripheral arterial disease • Heart echinococcosis: new data - new questions • One-stage complete repair of thoracic aorta including aortic valve – a case report • Impact of etiology of mitral regurgitation (MR) on outcome after interventional mitral valve repair using the MitraClip system 30th Cardiovascular Surgical Symposium – CSS THURSDAY, March 8, 2012 – SCIENTIFIC PROGRAM 14.00 – 15.30 EuRADa – European Registry of Aortic Disease 15.30 – 17.00 Session A: Principles of Long-term Support Chair: E. Potapov (Berlin), D. Zimpfer (Vienna) • Nine years of ventricular assist device program in IKEM 17.30 – 19.20 Session B: Devices for Long-term Support Chair: U. Livi (Udine), H. Schima (Vienna) KEYNOTE LECTURE:
• 30 years of mechanical circulatory support 30th Cardiovascular Surgical Symposium – CSS FRIDAY, March 9, 2012 – SCIENTIFIC PROGRAM Chair: S. Folkmann (Vienna), E. Weigang (Mainz) • Low rate of bleeding events under a mild anticoagulation regimen in the use of the HeartMate II left ventricular assist device • Exercise hemodynamics and quality of life after • The outcome in octogenarians after cardiac surgery • Endovascular exclusion of a glass shaped saccular aneurysm with Endologix stent graft in a very high risk patient • Intraoperative assessment of blood flow using the new ICG imaging system in cardiovascular surgery • Characteristics of TAV- and BAV-associated thoracic aortic aneurysms – smooth muscle cel biology, expression profiling, and histological analyses • TEVAR in Aortic type B dissection - impact of • Outcome of aortic valve sparing by reimplantation in patients with aortic regurgitation and dilatation of the ascending aorta. The role of the echocardiographic evaluation • ECMO in pregnancy as poor prognostic factor: A single center experience • Rewarming of accidental hypothermic cardiac arrest with extra-corporeal circulation. • Actual state of circulatory support systems in pediatrics • Short-term ventricular assist device as a bridge to transplantation • Update of mechanical circulatory support: experiences 30th Cardiovascular Surgical Symposium – CSS FRIDAY, March 9, 2012 – SCIENTIFIC PROGRAM • Surgeons fear of a corpus alienum: Re-sternotomy as an unwelcome side-effect of unknown fizzy tablet intake?! • Pulmonary atresia with ventricular septal defect and major aortopulmonary col ateral arteries: outcome improvement • Endoprosthesis for thoraco-abdominal Typ-B dissection scarce distal landingzone • Effect of diastolic dysfunction on the outcome of coronary bypass grafting surgery; • Case study: aortic insufficiency, caused by rare anatomical feature • An unusual aortic valve sparing: David ‘reimplantation’ and cusp extension Chair: S. Folkmann (Vienna), M. Gorlitzer (Vienna) 15.30 – 17.00 Session A: Extracorporeal Membrane Oxygenation Chair: A. Rajek (Vienna), C. Schmid (Regensburg) • Percutaneous VA ECMO for acute resuscitation • ECMO support in the pediatric population 17.30 – 19.00 Session B: Short- and Long-term Support Chair: M. Strüber (Vienna), G. Trittenwein (Vienna) • Resuscitation for avalanche accidents


Prescription Program Drug list — To be used by members who have a formulary drug plan. Anthem Blue Cross California prescription drug benefits include medications available on the Anthem Drug List. Our prescription drug benefits can offer potential savings when your physician prescribes medications on the drug list. For more information about your drug plan, you can do A. The Anth

West chester g

WEST CHESTER G.I. ASSOCIATES Procedure Date: _______/______/______ Bowel Preparation with Gatorade, Dulcolax & Miralax □ DO NOT EAT OR DRINK ANYTHING 4 HOURS BEFORE YOUR SCHEDULED ARRIVAL TIME. □ You must be accompanied by a friend or relative to drive and/or assist you home. We WILL NOT discharge you to a cab, bus or other transportation service without a responsible

© 2010-2014 Pdf Medical Search